Whole-brain radiotherapy of NSCLC patients with multiple brain metastases – an update
Non-small cell lung cancer (NSCLC) constitutes approximately 85% of all lung cancers, with the majority of patients having advanced disease at presentation. Between 10-20% present with brain metastases (BM) and up to 40% of patients will develop BM. The overall median survival is reported to average three to four months if treated with whole brain […]
Dr Swee-Ling Wong, Dr Ruheena Mendes, Professor Siow Ming Lee
University College London Hospitals NHS Foundation Trust